Over 35 million people worldwide are reported to suffer from Alzheimer’s disease (AD). With healthcare advances and marked increase in life expectancy, there is an ever-increasing incidence of AD. Longevity and the continuous improvement of peri-operative medicine, reducing mortality and morbidity, have led to an exponential increment in surgery and, as a consequence, a larger number of aged patients are undergoing surgery. While anesthetics are indispensable clinical tools and generally considered safe and effective, in some situations there is a growing concern about the potential neurotoxicity of these agents.

Anesthetics and Alzheimer's disease. Editorial.

FODALE, Vincenzo
2010-01-01

Abstract

Over 35 million people worldwide are reported to suffer from Alzheimer’s disease (AD). With healthcare advances and marked increase in life expectancy, there is an ever-increasing incidence of AD. Longevity and the continuous improvement of peri-operative medicine, reducing mortality and morbidity, have led to an exponential increment in surgery and, as a consequence, a larger number of aged patients are undergoing surgery. While anesthetics are indispensable clinical tools and generally considered safe and effective, in some situations there is a growing concern about the potential neurotoxicity of these agents.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/2327722
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 1
social impact